Epigenetic alterations

If your DNA is the hardware, the epigenome is the software — the layer of chemical switches that decides which genes are on or off in each cell, and it drifts out of tune as you age. This matters because, unlike DNA mutations, these marks are reversible, they are what "epigenetic clocks" read to estimate your biological age, and they respond to the ordinary levers — diet, exercise, sleep, stress. The honest caveat: the clocks are the most developed aging biomarkers we have but the consumer versions are noisy, and the dramatic "age reversal" results come from small studies and from mice.

Epigenetic alteration is the third of the twelve hallmarks of aging, and the one that best explains why behaviour matters so much. Your DNA sequence is essentially fixed for life, yet only about 20–30% of the variation in how long people live is attributable to inherited gene variants, with the rest shaped by environment, diet, lifestyle and chance.^[1] That is a statement about spread across a population, not about any one person's lifespan being 30% genetic. That split is contested — a 2026 reanalysis argues the twin estimates are deflated by accidents and infections, and puts the heritability of intrinsic ageing above 50% once those are stripped out.^[2] The argument for behaviour does not rest on the exact figure. Those outside influences reach the genome through the epigenome: a layer of reversible chemical marks sitting on top of the DNA that controls which genes are switched on without changing the underlying code. As we age, that control layer degrades — cells lose their precise identities, and tissues drift away from the gene-activity patterns of youth.^[3]

How confident should you be

Descriptive — Strong. Measurement — Strong for comparing groups, Weak for individuals. Intervention — Moderate at best.

That the epigenome drifts with age, and that the drift is reversible in principle, is well established. That methylation-based clocks track health and mortality across populations is Strong — they are the most developed aging biomarkers available, though not the best-performing on every test. That your clock reading means anything is Weak: the clocks disagree with one another, and the same blood sample measured twice returns different ages. Everything aimed at moving the clock deliberately is Weak, with one Moderate exception: the calorie-restriction result comes from a randomised trial, though the methylation analysis within it was not pre-specified.

The software of the cell

Three interlocking systems make up the epigenome, and all three slip with age.^[4]

DNA methylation is the most studied. A small chemical tag (a methyl group) is attached to the DNA at specific spots, usually where a cytosine "letter" sits next to a guanine — a so-called CpG site. A cluster of these tags on a gene's control region typically switches that gene off. Methylation is what keeps a liver cell behaving like a liver cell and a skin cell like a skin cell, by silencing the genes each doesn't need.

Histone modifications work on the spools. DNA is wound around protein spools called histones, and chemical tags on those spools change how tightly the DNA is packed. Adding an acetyl tag (acetylation) loosens the packing and opens genes for reading; removing it tightens the packing and shuts them. The enzymes that add and remove these tags — and the ones that physically slide the spools along the DNA — are a major control system, and several of them are druggable.

Non-coding RNAs are a third layer: RNA molecules that don't code for proteins but fine-tune which genes are expressed.

The crucial property of all three is that they are reversible. A mutation is a permanent typo in the code; an epigenetic mark is a pencil annotation that can be erased and rewritten. That reversibility is exactly what makes the epigenome a target for intervention — and what separates this hallmark from genomic instability, where the damage is to the code itself.

How the aging epigenome drifts

Strong — the two-directional drift is one of the best-replicated findings in the field.

Aging doesn't simply add or remove marks uniformly; it scrambles them in a characteristic, two-directional way.^[5]

Global loss of methylation. Across the genome as a whole, methylation tags are gradually lost — especially from the vast stretches of repetitive DNA that are normally kept silenced. Among those sequences are "jumping genes" (transposable elements): ancient viral relics that, when their methylation silencing erodes, can reactivate, copy themselves around the genome, and provoke both genetic damage and sterile inflammation — inflammation with no infection behind it.^[6] This is one of the molecular threads tying epigenetic drift to inflammaging.

Local gain of methylation. At the same time, methylation accumulates on the control regions of specific important genes — including tumour-suppressor genes and genes governing cell identity and repair — switching them off when they're needed.^[7] The combination is the worst of both worlds: the genes that should be quiet get noisy, and the genes that should be active get silenced.

A parallel structural change is the gradual unravelling of heterochromatin — the densely packed, switched-off regions of the genome laid down early in development. The "heterochromatin loss" model of aging holds that these silent domains progressively break down, exposing genes that should stay dormant.^[8] The same machinery is destabilised in the accelerated-aging disease Hutchinson-Gilford progeria, where a faulty nuclear-envelope protein loosens heterochromatin's anchoring — one of the links between this hallmark and the progeroid syndromes discussed under genomic instability.

The enzymes you can nudge: histones and sirtuins

Weak / preclinical — striking results in mice, nothing established in people.

Because the marks are written and erased by enzymes, those enzymes are obvious drug targets, and animal work is encouraging if still early. Blocking the enzymes that remove acetyl tags — histone deacetylases, or HDACs — restored youthful chromatin and prevented age-related memory loss in mice; conversely, switching off a specific tag-adding enzyme called KAT7 relieved cellular senescence and extended lifespan in mice.^[9] These are striking proofs of principle in animals, not human therapies.

The best-known of these enzymes are the sirtuins, a family of "deacetylases" that strip acetyl tags off histones and other proteins. Their importance for longevity is that they only work when fuelled by nicotinamide adenine dinucleotide (NAD⁺), a molecule whose levels fall with age — which makes sirtuins a sensor that ties your metabolic state to your chromatin. Specific sirtuins guard genomic stability and mitochondrial function, and SIRT6-deficient mice in particular age faster.^[10] But the popular leap from "sirtuins matter" to "sirtuin-boosting supplements extend life" is not supported: in mammals the lifespan effects of revving sirtuins up are modest and inconsistent, and the early fly and worm results were partly confounded by genetic background. This is the mechanistic backdrop to the NAD⁺ precursors and resveratrol covered under geroprotectors — real biology, thin human longevity evidence.

Epigenetic clocks: the most developed aging biomarkers we have

Strong as a research tool for comparing groups; Weak for any individual reading. They are the most developed human aging biomarkers, but "most developed" is not "best": a simple composite of seven inflammatory blood markers out-predicted thirteen of these clocks for four-year mortality. See the hallmarks hub.

The single most consequential product of this field is the epigenetic clock — an algorithm that reads methylation at a few hundred CpG sites and returns an estimate of biological age that can differ from your age in years. The clocks have evolved through generations, each better aimed at health rather than just calendar age.^[11]

First generation (Horvath, Hannum) was trained to predict chronological age. Accurate at that, but only loosely tied to health.
Second generation (PhenoAge, GrimAge) was trained against clinical markers and mortality, and these are the ones that actually track health: across nine clocks estimated from a single large cohort, the first- and fourth-generation versions were not as closely tied to socioeconomic status or health outcomes as the second- and third-generation ones.^[12]
Third generation (DunedinPACE) doesn't report an age at all — it reports a rate, the pace of biological aging per calendar year, which makes it the most sensitive tool for detecting whether an intervention is working.
Fourth and fifth generation (causality-enriched and organ-system clocks) try to isolate the methylation changes that actually drive damage rather than merely correlate with age — the same causal logic behind the DamAge and AdaptAge metrics discussed under hallmarks of aging.

The clocks have genuine biological grip: higher body weight and metabolic dysfunction show up as accelerated clocks, and an accelerated clock can appear in the blood of women years before a breast-cancer diagnosis.^[13] Lower socioeconomic status does too, most clearly on the second- and third-generation clocks.^[14] In a large German aging cohort, the pace-of-aging and organ-system clocks tracked cognitive decline most consistently — a result so far reported only in a preprint that has not been peer-reviewed.^[15]

But can you trust your own clock result?

Weak — the consumer tests are not reliable enough to act on, and Caution applies to what is sold on top of them.

The leap from "powerful research tool" to "reliable personal test" is where the field gets oversold, and the caveats are the same ones that sink consumer telomere testing. Start with the most awkward one: the clocks do not agree with each other. Estimated side by side from a single cohort, nine widely used clocks read different sets of methylation sites and do not correlate strongly among themselves.^[16] There is no single quantity called "your epigenetic age" that they are all approximating. The root problem is technical reliability: when the same blood sample is measured twice, the widely used clocks return different ages — a median of one to two years apart, and in the worst case nearly nine, against a real between-person spread of only three to five years — because the individual methylation probes they read are themselves noisy — an unreliability large enough to swamp the small differences a consumer test claims to detect, and one that has to be engineered out before a clock can track an individual over time.^[17]^[18]

Sample type matters. Blood is the gold standard, because it's a well-characterised mix of immune cells. Many consumer kits use saliva, which is part immune cells and part cheek-lining cells with entirely different methylation — and feeding saliva into a blood-trained clock without careful correction introduces large errors.
Platform matters. Results shift with the measurement technology and there are no universal reference standards between labs, so the same person can get markedly different "biological ages" from different providers.
No regulatory validation. No epigenetic clock is approved as a clinical endpoint, and companies routinely pair a proprietary, unvalidated algorithm with generic lifestyle advice.

So a single consumer clock reading is not something to act on. The clocks earn their keep in research — comparing groups, tracking interventions across many people — far more than in telling one individual their "true age."

What actually moves the clock

Weak overall, Moderate for calorie restriction. One randomised trial with a post hoc endpoint, one pilot with 43 participants, and a set of observational associations.

The interventions with the best evidence for slowing epigenetic aging are, once again, the familiar ones — and the strongest single piece of evidence is a real randomised trial.

Caloric restriction has the best evidence — with one caveat worth stating up front. The CALERIE trial randomised 220 healthy adults without obesity to a 25% calorie-restriction target or an ad-libitum diet for two years, and the restricted group significantly slowed their pace of aging on the DunedinPACE clock. The caveat is that the methylation analysis was performed post hoc — it was not what the trial was designed to test — so this is randomised data analysed after the fact rather than a pre-specified result. Adherence fell well short of the target, at roughly 12% average restriction rather than 25%.^[19] The slowing was modest — a small effect on one clock, with no accompanying evidence that it translates into fewer deaths. Notably, the effect appeared on the pace-of-aging clock and not at all on the static clocks, PhenoAge and GrimAge — a clean null there, and a reminder that "which clock" changes the answer.

Diet supplies the raw material for methylation. The methyl tags themselves are built from nutrients in "one-carbon metabolism" — folate, vitamin B12, choline, and methionine — so a diet rich in these methyl donors is the biochemical rationale behind the dietary protocols aimed at the epigenome. A small eight-week trial — the authors call it a pilot — combining exactly such a methyl-donor-rich diet with sleep, exercise, and probiotics reported a roughly three-year drop in Horvath-clock age versus controls — an eye-catching result, but from one small study (43 men) that needs replication before it means much.^[20] Several plant compounds in that same protocol also nudge the relevant enzymes — broccoli-derived sulforaphane and dietary polyphenols modulate the acetyl-removing HDACs and the methylation-adding DNA methyltransferases (DNMTs) — though these are mechanistic signals, not proven longevity interventions.^[21]

Exercise, sleep, and stress. Exercise is the lever with the weakest direct epigenetic evidence of the four, which is worth saying plainly because it is the one most often asserted. What exists sits inside multidomain programmes that also change diet, so the exercise contribution cannot be isolated — see the frail-older-adults trial below. Sleep pushes the other way, though less simply than usually reported. In the Young Finns cohort the robust and actionable finding is that symptoms of obstructive sleep apnoea track accelerated epigenetic ageing independently of other health factors — see sleep-disordered breathing. Shift work did not produce a clean dose-response: its effect showed on one clock in one model only, and among people with little shift-work history, insomnia and sleep deprivation were associated with more acceleration than in long-term shift workers, which the authors read as possible adaptation.^[22] Acute sleep loss does shift methylation on the core clock genes.^[23]^[24]^[25] Chronic psychological stress is widely held to accelerate the clocks, though the mechanism is not established here. The meditation evidence is narrower than it is usually reported: there was no overall difference between long-term meditators and controls, and the protection appeared only in those over about 52, alongside a small gradient of roughly a quarter of a year less epigenetic age acceleration per additional year of practice.^[26] Such studies also cannot rule out that people who meditate for decades differ in other ways. A multidomain lifestyle programme in frail older adults — supervised exercise three days a week plus nutritional support — improved both physical function and epigenetic-aging markers in a randomised trial. It is the best exercise-containing evidence on this page and it is still very small: 47 people randomised, with methylation measured in only 24 of them, eight of those controls, after the pandemic disrupted recruitment. It reinforces the general pattern rather than settling anything — the package moves the needle, and no study here isolates which part did the work.^[27]

The reprogramming frontier

Weak / preclinical, and Caution on the safety question — the same factors that rejuvenate cells cause tumours if left on.

The most radical idea in the field is partial reprogramming: briefly switching on the four "Yamanaka factors" — the same genes that can revert an adult cell all the way back to a stem-cell state — but only transiently, so that aged epigenetic marks are wiped clean while the cell keeps its identity. In mice, this approach restored youthful gene-activity patterns to nerve cells in the eye and reversed age-related vision loss.^[28] Applied long-term and intermittently to normally aging mice, it rejuvenated skin and kidney, reversed the epigenetic clock, and damped genes for inflammation and senescence — with the authors concluding such regimens can be designed to be safe.^[29] Later gene-therapy versions extended lifespan in aged animals.^[30]

The catch is severe and obvious: the same factors that rejuvenate cells can, if expressed too long or too strongly, drive uncontrolled growth and tumours — this is the well-known hazard of the reprogramming factors, and this article does not have a single citation for it. Making the reset transient and tightly controlled is the central safety challenge. One line of work replaces the genetic factors with small-molecule "chemical reprogramming" cocktails, six of which have been identified in screens.^[31] None of it is near ready for healthy humans. This is a frontier worth watching, not a therapy to seek out.

What this does and doesn't tell you

What it tells you: epigenetic alterations are the hallmark that makes the case for behaviour — a large share of the variation in how we age is non-genetic and runs through reversible marks, though how large is genuinely contested and this site does not pick a number. The epigenetic clocks built on those marks are the most developed human biomarkers of aging, the calorie-restriction evidence (CALERIE) comes from a genuine randomised trial, albeit from a post hoc analysis within it, and the levers that move the clocks are diet, exercise, sleep, and stress — the same short list that runs through this whole site.

What it doesn't tell you: that a consumer clock reading is precise enough to act on (it usually isn't), that any supplement reliably reverses your epigenetic age, or that reprogramming is anywhere near safe for people. The dramatic numbers — "three years younger in eight weeks," "vision restored" — come from a single small trial and from mice, respectively. The durable message is the unglamorous one: the epigenome is tunable, and the proven tuning knobs are the ordinary ones.